huRH105-sSPDB-DM4

N/A

Report date: 2023/09/05 18:02:08

Base Information

Drug NamehuRH105-sSPDB-DM4
Drug Alias NamehuRH105-sSPDB-DM4 antibody drug conjugatehuRH105-sSPDB-DM4huRH-105-sSPDB-DM-4
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionAnti-CD105Tubulin polymerisation inhibitors
TargetsEndoglinTubulin
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesImmunogen Inc
China Registration ClassN/A

Develop Information

Active CompaniesImmunogen Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A